Author/Authors :
Çanga, Yiğit Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital - Clinic of Cardiology, Turkey , Osmonov, Damirbek Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital - Clinic of Cardiology, Turkey , Karataş, Mehmet Baran Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital - Clinic of Cardiology, Turkey , Durmuş, Gündüz Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital - Clinic of Cardiology, Turkey , İlhan, Erkan Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital - Clinic of Cardiology, Turkey , Kırbas, Veli Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital - Clinic of Cardiology, Turkey
Abstract :
The European monitoring center for Drugs and Drug Addiction declared that one in five adults in Europe have used marijuana or related drugs like hashish at June 2008 report. While heroin, ecstasy and cocaine were seen as the most harmful illicit drugs, cannabis was often viewed as a relatively benign drug, as alcohol or tobacco. Acute myocardial infarction (AMI) is an uncommon diagnosis among young patients. Smoking cigarettes is the most prevalent risk factor, which has well known detrimental effects on atheromatous plaque formation in this age group (1). Although we need more studies to investigate the contribution of cannabis smoking to coronary artery disease process, it was proposed that cannabis smoking is a trigger of acute cardiovascular events according to several case reports (2-3).
